acetylcysteine has been researched along with carboplatin in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benbow, U; Brinckerhoff, CE; Hamilton, JW; Maitra, R | 1 |
| Bennett, LC; Hale, C; Muldoon, LL; Neuwelt, EA; Purcell, SE; Walker-Rosenfeld, SL | 1 |
| Beijnen, JH; Huitema, AD; Rodenhuis, S; van Maanen, MJ | 1 |
| Kilic, MA; Kilinc, M; Okur, E; Tolun, FI; Yildirim, I | 1 |
| Chang, CC; Chen, CC; Cheng, CF; Chou, Y; Juan, SH; Li, HF; Lin, H; Sue, YM | 1 |
| Bhat, MK; Chaube, B; Pandey, V | 1 |
| Cao, L; Cheng, WH; Fu, Y; Tzeng, TJ; Zeng, H | 1 |
| Butini, S; Campiani, G; Lennon, JC; O'Meara, A; Williams, DC; Zisterer, DM | 1 |
| Cao, S; Han, B; Ling, X; Wang, H; Xu, J; Zhang, B; Zhang, X; Zhong, H; Zhong, R | 1 |
| Bartos, P; Bartunkova, J; Chovanec, J; Cibula, D; Fucikova, J; Hraska, M; Hrnciarova, T; Kieszko, D; Klat, J; Knapp, P; Korolkiewicz, RP; Mallmann, P; Melichar, B; Minar, L; Novotny, Z; Pluta, M; Rob, L; Spacek, J; Spisek, R; Valha, P | 1 |
2 trial(s) available for acetylcysteine and carboplatin
| Article | Year |
|---|---|
Safety and efficacy of dendritic cell-based immunotherapy (DCVAC/LuCa) combined with carboplatin/pemetrexed for patients with advanced non-squamous non-small-cell lung cancer without oncogenic drivers.
Topics: Acetylcysteine; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Dendritic Cells; Humans; Immunotherapy; Lung Neoplasms; Pemetrexed; Prospective Studies | 2022 |
Safety and efficacy of dendritic cell-based immunotherapy DCVAC/OvCa added to first-line chemotherapy (carboplatin plus paclitaxel) for epithelial ovarian cancer: a phase 2, open-label, multicenter, randomized trial.
Topics: Acetylcysteine; Adolescent; Adult; Aged; Aged, 80 and over; Animals; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Ovarian Epithelial; Dendritic Cells; Female; Humans; Immunotherapy; Mice; Middle Aged; Paclitaxel; Young Adult | 2022 |
8 other study(ies) available for acetylcysteine and carboplatin
| Article | Year |
|---|---|
Selective inhibition of collagenase-1, gelatinase A, and gelatinase B by chemotherapeutic agents.
Topics: Acetylcysteine; Antineoplastic Agents; Carboplatin; Cisplatin; Doxorubicin; Gelatinases; Humans; Matrix Metalloproteinase 1; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Melanoma; Metalloendopeptidases; Mitomycin; Neoplasm Invasiveness; Protease Inhibitors; Tumor Cells, Cultured | 1999 |
Rescue from enhanced alkylator-induced cell death with low molecular weight sulfur-containing chemoprotectants.
Topics: Acetylcysteine; Alkylating Agents; Antimetabolites, Antineoplastic; Apoptosis; Buthionine Sulfoximine; Carboplatin; Cell Survival; Cytoprotection; Drug Interactions; Humans; Molecular Weight; Protective Agents; Thiosulfates; Time Factors; Tumor Cells, Cultured | 2001 |
Urinary excretion of thioTEPA and its metabolites in patients treated with high-dose cyclophosphamide, thioTEPA and carboplatin.
Topics: Acetylcysteine; Adolescent; Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Aziridines; Breast Neoplasms; Carboplatin; Creatinine; Cyclophosphamide; Dose-Response Relationship, Drug; Female; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Models, Chemical; Neoplasms, Germ Cell and Embryonal; Thiotepa; Time Factors; Triethylenephosphoramide | 2001 |
Effect of N-acetylcysteine on carboplatin-induced ototoxicity and nitric oxide levels in a rat model.
Topics: Acetylcysteine; Animals; Antineoplastic Agents; Biomarkers; Carboplatin; Cochlea; Disease Models, Animal; Evoked Potentials, Auditory, Brain Stem; Follow-Up Studies; Free Radical Scavengers; Glutathione Peroxidase; Hearing Loss, Sensorineural; Male; Nitric Oxide; Rats; Rats, Sprague-Dawley; Spectrophotometry; Treatment Outcome | 2007 |
Activation of a nuclear factor of activated T-lymphocyte-3 (NFAT3) by oxidative stress in carboplatin-mediated renal apoptosis.
Topics: Acetylcysteine; Animals; Antineoplastic Agents; Apoptosis; Carboplatin; Caspase 3; Cell Nucleus; Epithelial Cells; Kidney Tubules; Luciferases; Mice; Mice, Transgenic; NADPH Oxidases; NFATC Transcription Factors; Oxidative Stress; Protein Carbonylation; Reactive Oxygen Species; Transfection | 2010 |
Hyperglycemia regulates MDR-1, drug accumulation and ROS levels causing increased toxicity of carboplatin and 5-fluorouracil in MCF-7 cells.
Topics: Acetylcysteine; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Carboplatin; Cell Line, Tumor; Female; Fluorouracil; Glucose; Humans; Hyperglycemia; Inhibitory Concentration 50; NF-kappa B; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Verapamil | 2011 |
Methylseleninic acid sensitizes Notch3-activated OVCA429 ovarian cancer cells to carboplatin.
Topics: Acetylcysteine; Antineoplastic Agents; Ataxia Telangiectasia Mutated Proteins; Carboplatin; Cell Cycle; Cell Line, Tumor; Chromones; DNA-Binding Proteins; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Histones; Humans; Morpholines; Organoselenium Compounds; Ovarian Neoplasms; Phosphorylation; Receptor, Notch3; Receptors, Notch; RNA, Messenger; Thioxanthenes | 2014 |
Involvement of AMP-activated protein kinase in mediating pyrrolo-1,5-benzoxazepine-induced apoptosis in neuroblastoma cells.
Topics: Acetyl-CoA Carboxylase; Acetylcysteine; AMP-Activated Protein Kinases; Animals; Antineoplastic Agents; Antioxidants; Apoptosis; Carboplatin; Cell Line, Tumor; Female; Humans; Mechanistic Target of Rapamycin Complex 1; Mice, Inbred BALB C; Mice, Nude; Myeloid Cell Leukemia Sequence 1 Protein; Neuroblastoma; Oxazepines; Phosphorylation; Pyrroles; Reactive Oxygen Species; Tubulin Modulators; Tumor Burden | 2016 |